Serial #79232026
LIVE

Serial Number

79232026

Owner

Eckert & Ziegler SE

Attorney

Bruce S. Londa

Filing Date

Nov 14, 2017

Add to watchlist:

No watchlists yet
View on USPTO

Serial #79232026 Trademark

Serial Number: 79232026 • Registration: 5905660

Serial #79232026 is a trademark filed by Eckert & Ziegler SE on November 14, 2017. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 7 (Machinery), Class 9 (Computers & Electronics), Class 10 (Medical Apparatus), Class 37 (Building & Construction), Class 39 (Transportation & Storage), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

Eckert & Ziegler SE

Robert-Rössle-Str. 10

Entity Type: 98

Eckert & Ziegler Strahlen- und Medizintechnik AG

Robert-Rössle-Str. 10

Entity Type: 99

Trademark Details

Filing Date

November 14, 2017

Registration Date

November 12, 2019

Published for Opposition

August 27, 2019

Goods & Services

Radioactive substances for scientific and chemical purposes; chemical products, namely, sealed radioactive alpha, beta, gamma, x-ray or neutron sources, namely, sealed radioactive alpha, beta, gamma, x-ray or neutron sources, radioactive alpha, beta, gamma, x-ray or neutron sources in the form of standardized solutions, tracer gasses, Ge-68/Ga-68 radionuclide generator, Y-90 Chloride Solution, chemical substances for use as nuclear fissionable material for science and industry for industrial, scientific and research purposes; chemical reagents and preparations for industrial, scientific and research purposes, other than for medical or veterinary purpose; fissionable chemical elements for scientific research use and for nuclear research applications; radioactive elements being nuclides and isotopes for industrial, scientific and research purposes; radioactive preparations for chemical purposes, namely, nuclides and radionuclides, radioactive and radiographic sources as well as radioactive sources and compounds for use in radiographic techniques; chemical reagents for use with the aforesaid goods other than for medical or veterinary purpose; isotopes for industrial purposes; radioactive elements for scientific purposes; chemical reagents, other than for medical or veterinary purposes; chemical salts; salts for industrial purposes; plasticizers for industrial purposes; radiodiagnostic in-vivo means for scientific purposes, namely, radioactive implantable seeds; radiochemical products, namely, radioactive or stable isotopes, Ge-68/Ga-68 radionuclide generator, Y-90 Chloride Solution for scientific purposes; radioactive materials for laboratory purposes, namely, radioactive or stable isotopes, Ge-68/Ga-68 radionuclide generator, Y-90 Chloride Solution; radioactive elements for scientific purposes; chemical products, namely, Ge-68/Ga-68 radionuclide generator, Y-90 Chloride Solution for laboratory analysis, except for medical or veterinary purposes

Robots and automation technology, namely, industrial robots for medical and other applications

Transport of medical waste and special waste; storage of radioactive waste

Installation, maintenance and repair of scientific apparatus and instruments; installation, maintenance and repair of radiological apparatus and instruments; consultancy relating to all the aforesaid services; all the aforesaid services to the extent that they are included in this class

Research and development of radioactive sources of radiation; development of machinery, devices and apparatus for the production of radioactive sources of radiation; research in the field of medical technology and in the field of immunotherapy and immuno- diagnostics; development of robots and automation technology for medical and other applications; development of treatment methods, procedures and products for immunotherapy and immuno-diagnostics; calibrating and recalibrating of radiologic apparatus and instruments including apparatus and instruments for determining, measuring and monitoring radiographic potential, radioactivity and radioactive pollution levels, and supply and replacement of radioactive sources for use therewith; calibrating and recalibrating of standard radioactive preparations; carrying out measurements, namely, radiation measurements, for radiation protection services; dosimetry monitoring services in relation to personnel and the environment; consultancy relating to all the aforesaid services; biological research; chemist services, physicist, services namely, research in the field of physics; service of a technical measuring and testing laboratory; chemical analyses; carrying out scientific investigations for medical purposes; research and development of new products for others; research in the field of technology, chemistry, biochemistry, physics, cosmetics, pharmacy, scientific laboratory services; material testing; physics research; scientific research; scientific research for medical purposes; scientific and technological services and research in the field of nuclear medicine and molecular imaging and of radio-isotopes, and the applications, transport, use, storage, maintenance and disposal thereof; pharmaceutical research and development; development of pharmaceutical preparations and medicines; consultancy services related to nuclear technology

Radiotherapy apparatus and instruments, namely, low-dose rate (LDR) seeds, TP/TPV Applicator, low-dose rate (LDR) Needles, high-dose rate (HDR) afterloader, high-dose rate (HDR) applicators, Ru-106 Eye Applicators, I-125 Ophthalmic Seeds, bolus material; blood analyzers for medical diagnostic use; electrodes for medical purposes; injection syringes; medical instrument cases for use by doctors and surgeons; special cases for medical instruments, namely, cases fitted for medical instruments and/or for use by doctors; face masks for medical staff; medical apparatus and instruments, namely, radiosynthesis equipment for the manufacture of radionuclides and vacuum pumps for medical purposes; radiological apparatus for medical purposes, low-dose rate (LDR) seeds, TP/TPV Applicator, low-dose rate (LDR) Needles, high-dose rate HDR afterloader, high-dose rate (HDR) applicators, Ru-106 Eye Applicators, I-125 Ophthalmic Seeds, bolus material, radiolabelled compounds; special containers made for medical waste; radiation therapy equipment, namely, radiation therapy machines, low-dose rate (LDR) seeds, TP/TPV Applicator, low-dose rate (LDR) Needles, high-dose rate (HDR) afterloader, high-dose rate (HDR) applicators, Ru-106 Eye Applicators, I-125 Ophthalmic Seeds, bolus material; radioisotope therapy apparatus for medical purposes; radio-oncological irradiation apparatus, namely, high-dose rate (HDR) afterloader, low-dose rate (LDR) seeds, TP/TPV applicator for medical purposes; radio-oncological irradiation instruments for medical purposes, namely, low-dose rate (LDR) seeds, TP/TPV Applicator, low-dose rate (LDR) Needles, high-dose rate (HDR) afterloader, high-dose rate (HDR) applicators, Ru-106 Eye Applicators, I-125 Ophthalmic Seeds, bolus material; linear accelerator for medical purposes in radiotherapy, namely, linear accelerators for external beam radiation treatments; radiation therapy instruments for medical purposes, namely, radiation therapy machines, low-dose rate (LDR) seeds, TP/TPV Applicator, low-dose rate (LDR) Needles, high-dose rate (HDR) afterloader, high-dose rate (HDR) applicators, Ru-106 Eye Applicators, I-125 Ophthalmic Seeds, bolus material; medical devices for dosimetry purposes in the field of radiotherapy; nuclear medical tomographic scanner; medical diagnostic imaging apparatus for nuclear medicine; cancer irradiation apparatus for medical purposes, namely, low-dose rate (LDR) seeds, TP/TPV Applicator, low-dose rate (LDR) Needles, high-dose rate (HDR) afterloader, high-dose rate (HDR) applicators, Ru-106 Eye Applicators, I-125 Ophthalmic Seeds, bolus material; cancer irradiation instruments medical purposes, namely, low-dose rate (LDR) Needles, high-dose rate (HDR) Applicators

Sealed radioactive substances for medical purposes; radioactive medicines for veterinary purposes, namely, medicines for the treatment of impaired cell or tissue growth; radioactive diagnostic agents for medical purposes; radioactive pharmaceutical and veterinary products, namely, HDR afterloader systems; radioactive substances for medical purposes, namely, diagnostic preparations being Ge-68/Ga-68 radionuclide generator and Y-90 Chloride Solution; radioactive salts for medical purposes; isotopes for commercial and medical purposes; pharmaceutical preparations for the treatment of cancer; radioactive substances for medical purposes, namely, pharmaceutical and veterinary preparations being Ge-68/Ga-68 radionuclide generator and Y-90 Chloride Solution for use in nuclear medicine

Scientific apparatus and instruments, namely, radiosynthesis and radiochromatography equipment; measuring or monitoring apparatus and instruments, namely, quality control/radiochromatography equipment, radiation survey meters, dose meters, personal dosimeters; radiological apparatus and instruments for industrial, scientific and educational purposes, namely, radiosynthesis and radiochromatography equipment; Gamma radiography projectors and collimators of radioactive sources for radioactive sources used for industrial non-destructive testing applications; apparatus and instruments for detecting, measuring or monitoring radiation potential, radioactivity content and radioactive contamination level, namely, radiation survey meters, dose meters and personal dosimeters; dosimeter; measuring instruments for checking personal doses, namely, personal dosimeters; holders, containers and capsules for radioactive sources, namely, source capsules, source holders, pigtails; glassware for laboratory purposes; computer software for the medical field for dose calculation, exposure times, dose calibration, dose measurement, dose recording and management, patient management and for SagiPlan for HDR brachytherapy treatment planning; radiological apparatus for industrial purposes, namely, gamma-ray and X-ray apparatus not for medical purposes; software for dosimetry purposes in the field of radiation therapy

Filing History

CHANGE OF NAME/ADDRESS REC'D FROM IB
May 14, 2026 ADCH
TEAS SECTION 71 RECEIVED
May 12, 2026 ES71
NEW REPRESENTATIVE AT IB RECEIVED
Mar 26, 2026 NREP
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Nov 12, 2024 REM3
FINAL DECISION TRANSACTION PROCESSED BY IB
Jun 5, 2020 FINO
GENERIC MADRID TRANSACTION SENT TO IB
Mar 7, 2020 XXSS
GENERIC MADRID TRANSACTION CREATED
Mar 6, 2020 XXCR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Feb 12, 2020 FICR
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Feb 6, 2020 TCCA
REGISTERED-PRINCIPAL REGISTER
Nov 12, 2019 R.PR
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Nov 8, 2019 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Oct 23, 2019 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Oct 23, 2019 OPNR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Aug 27, 2019 NPUB
PUBLISHED FOR OPPOSITION
Aug 27, 2019 PUBO
NOTIFICATION PROCESSED BY IB
Aug 23, 2019 GPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Aug 7, 2019 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Aug 7, 2019 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Aug 7, 2019 NONP
ASSIGNED TO LIE
Jul 21, 2019 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Jul 15, 2019 CNSA
EXAMINER'S AMENDMENT ENTERED
Jul 15, 2019 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Jul 15, 2019 GNEN
EXAMINERS AMENDMENT E-MAILED
Jul 15, 2019 GNEA
EXAMINERS AMENDMENT -WRITTEN
Jul 15, 2019 CNEA
ASSIGNED TO EXAMINER
Jul 11, 2019 DOCK
PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
Jun 19, 2019 AMPX
TEAS VOLUNTARY AMENDMENT RECEIVED
Jun 19, 2019 PARI
TEAS/EMAIL CORRESPONDENCE ENTERED
May 29, 2019 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 28, 2019 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
May 28, 2019 ERFR
NOTIFICATION OF FINAL REFUSAL EMAILED
Jan 12, 2019 GNFN
FINAL REFUSAL E-MAILED
Jan 12, 2019 GNFR
FINAL REFUSAL WRITTEN
Jan 12, 2019 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Nov 20, 2018 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 20, 2018 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Nov 20, 2018 TROA
REFUSAL PROCESSED BY IB
Jun 9, 2018 RFNT
APPLICATION FILING RECEIPT MAILED
May 22, 2018 MAFR
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
May 21, 2018 RFCS
REFUSAL PROCESSED BY MPU
May 21, 2018 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
May 20, 2018 RFCR
NON-FINAL ACTION WRITTEN
May 19, 2018 CNRT
ASSIGNED TO EXAMINER
May 18, 2018 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 18, 2018 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
May 17, 2018 REPR